The upcoming Supreme Court’s decision in Dobbs v. Jackson Women’s Health is likely to change the landscape of clinical practice in prenatal genomic medicine. With the prospect of overturning Roe v. Wade and other key precedents that have protected the right to choose, America faces a collision between the technical possibilities of genomics and laws affecting reproductive health. Clinicians, prospective parents, and pregnant people may experience vastly different reproductive healthcare than has been available over the past three decades. This webinar explores the ELS challenges of this anticipated decision for clinicians, patients, and families. Lessons will be drawn from research in states with existing restrictive abortion laws. We will also ask how it may impact the training of genetic counselors and health providers in reproductive genomics and its likely effects on ongoing efforts to increase genomic medicine and assure tailored genomic care. Potential risks and other impacts will be explored with reference to the varying laws and policies across states as well as the diverse populations that seek reproductive services and care.
View the discussion with panelists Michelle McGowan, PhD and Aarti Ramdaney, MS, CGC moderated by Kimberly Mutcherson, JD.